Report for Welzel GE

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (1)

Title : Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes - Augeri_2005_J.Med.Chem_48_5025
Author(s) : Augeri DJ , Robl JA , Betebenner DA , Magnin DR , Khanna A , Robertson JG , Wang A , Simpkins LM , Taunk P , Huang Q , Han SP , Abboa-Offei B , Cap M , Xin L , Tao L , Tozzo E , Welzel GE , Egan DM , Marcinkeviciene J , Chang SY , Biller SA , Kirby MS , Parker RA , Hamann LG
Ref : Journal of Medicinal Chemistry , 48 :5025 , 2005
Abstract : Augeri_2005_J.Med.Chem_48_5025
ESTHER : Augeri_2005_J.Med.Chem_48_5025
PubMedSearch : Augeri_2005_J.Med.Chem_48_5025
PubMedID: 16033281